Non-alcoholic fatty liver disease (NAFLD) is common, affecting approximately 25% of the
general population. The evidence base for the investigation and management of NAFLD is …

Background Cirrhosis is the outcome of chronic liver disease of any etiology due to
progressive liver injury and fibrosis. Consequently, cirrhosis leads to portal hypertension …

The British Society of Gastroenterology in collaboration with British Association for the Study
of the Liver has prepared this document. The aim of this guideline is to review and …

Hepatocellular carcinoma is a common cancer with a poor prognosis, associated with high
economic costs and a significant burden of disease. While it is often asymptomatic in the …

Introduction: Patients with end-stage liver disease (ESLD) suffer from myriad symptoms due
to the systemic effects of the disease and unpredictable acute episodes, which contribute to …

Hepatocellular carcinoma (HCC) is a common complication in patients with chronic liver
disease and leads to significant morbidity and mortality. Liver disease and liver cancer are …

The mortality rate from chronic liver disease in the UK is rising rapidly, and patients with
advanced disease have a symptom burden comparable to or higher than that experienced …

End‐stage liver disease (ESLD) is associated with a high degree of morbidity and mortality
as well as symptom burden. Despite this, the rate of consultation with palliative care (PC) …

End-stage liver disease (ESLD) is characterized by the deterioration of liver function and a
subsequent high mortality rate. Studies have investigated the use of adult stem cells to treat …

Background Stroke is a prevalent neurological disease that can have a profound impact on
women's physical, psychosocial, and spiritual well-being. In many cases, women living with …